ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Anika Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Anika Therapeutics, INC. (Anika Therapeutics, INC. 401(k) Plan · EIN 04-3145961 · PN 001): $38.88M net assets, 259 active participants, and $7.99 per $10,000 (7.99 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAnika Therapeutics, INC.
Filing IdentifierAnika Therapeutics, INC. 401(k) Plan · EIN 04-3145961 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$38.88M
Active Participants259
Direct Admin Fee Rate$7.99 per $10,000 (7.99 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI